Skip to content
Research Article Open access CC BY 4.0

Development & Validation of RP-HPLC Method for the Estimation of Doravirine in Bulk and Pharmaceutical Dosage Form

A. Suneetha, G. I. Priyadarshini, V. Mounika, G. Aparna

Asian Journal of Research in Medical and Pharmaceutical Sciences · pp. 26–31 · Published 18 Dec 2021

10.9734/ajrimps/2021/v10i430174

Abstract

A simple, accurate, rapid and precise isocratic reversed phase high-performance liquid chromatographic method has been developed and validated for determination of Doravirine in tablets. The chromatographic separation was carried out on Dionex C18 (250 x 4.6mm, 5µ) with a mixture of methanol: 0.05M potassium dihydrogen phosphate (40:60%v/v) as a mobile phase at a flow rate of 1.5 mL/min. UV detection was performed at 306 nm. The retention time was 5.24 min for Doravirine. Calibration plot was linear (r2=0.999) over the concentration range of 200-600 µg/mL. The method was validated for accuracy, precision, specificity, linearity, robustness, LOD and LOQ. The proposed method was successfully used for quantitative analysis of tablets. No interference from any component of pharmaceutical dosage form was observed. Validation studies revealed that method is specific, rapid, reliable, and reproducible. The high recovery and low relative standard deviation confirm the suitability of the method for routine determination of Doravirine in bulk and tablet dosage form.

Doravirine RP-HPLC tablets.

Cited by 3

Spectrofluorimetric Method Development and Validation of Doravirine and Tablet Formulation

Rina Ikhar, Prafulla Sabale, Komal Somkuwar · Research Journal of Pharmacy and Technology · 2025

Development and Validation of RP-HPLC Method for the Quantification of Doravirine in Bulk and Tablet Formulation

Vaibhav Sawale, Prafulla Sabale, Komal Somkuwar · Research Journal of Pharmacy and Technology · 2025

HPTLC METHOD FOR SIMULTANEOUS ESTIMATION OF LAMIVUDINE, TENOFOVIR DISOPROXIL FUMARATE, AND DORAVIRINE

MRINALINI C. DAMLE, RITESH KHAIRNAR · International Journal of Pharmacy and Pharmaceutical Sciences · 2023

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

3

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.